Research libraryMOLEKUL / SOURCE RECORD

Pineal extracts: manufacturing and composition patent — RU2163129C1

В.Х. Хавинсон, В.Г. Морозов, В.И. Семенова, О.В. Чайка, Г.А. Рыжак · 2001 · RU2163129C1 · patent family 20236906

Published 2001-02-20.

Patent / reported experimentsFull text availableSource linked

Reported patent results

Reported findings

The disclosed extract was associated with lower reported glucose measures over 12 weeks, without a verified product-specific Epithalamin match.

Pineal-extract patent includes a type-2-diabetes clinical comparison: 33 treated patients and a 24-person control group.

Reported findings and study figures · 33-patient diabetes example, 24-person control narrative and Table 6 discussion.
MeasureResultComparison, timing and statistics
Fasting glycemiaReported decreases of 15%, 22% and 29.4% from baselineTreated group; baseline glucose values and modern allocation details not extracted · Weeks 2, 4 and 12
Postprandial glycemiaReported decreases of 18.2%, 28% and 41%Not absolute glucose concentrations · Weeks 2, 4 and 12
Control and HbA1cNo significant control-group glycemic change; treated HbA1c described as decreased without an extracted numerical valueNo invented HbA1c effect size

Concurrent diabetes care, incompletely specified allocation and patent reporting prevent a causal estimate. The extract is not synthetic AEDG; commercial Epithalamin equivalence and longevity benefit are unproven.

Source for the extracted data ↗ · Checked 2026-11-06

Patent claims and provenance

Platform context. The patent describes animal-pineal polypeptide complexes and proposed antioxidant or geroprotective uses, providing context for pineal-extract research.

A product-specific match to commercial Epithalamin was not established. This tissue-complex patent is not the defined AEDG Epitalon molecular patent, nor proof of human longevity.

Publication
RU2163129C1 ↗ · 2001-02-20
Earliest priority / filing
2000-06-29 / 2000-06-29
Original applicant / assignee
Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии"
Indexed status
Not shown; official status unverified · checked 2026-11-06
Patent family
20236906 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Method of preparing animal-origin complex of biologically-active polypeptides exhibiting antioxidant and geroprotection activities, pharmacological agent, and method for utilization thereof

Inventors: В.Х. Хавинсон; В.Г. Морозов; В.И. Семенова; О.В. Чайка; Г.А. Рыжак.

RU2163129C1

Original patent PDF ↗

Patent collection and status interpretation →

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • A product-specific match to commercial Epithalamin was not established. This tissue-complex patent is not the defined AEDG Epitalon molecular patent, nor proof of human longevity.
  • Concurrent diabetes care, incompletely specified allocation and patent reporting prevent a causal estimate. The extract is not synthetic AEDG; commercial Epithalamin equivalence and longevity benefit are unproven.
  • Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
  • Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Document format: Original patent text and indexed metadata

Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.

Related-report group: patent-family-20236906. Reports in this group are not assumed to be independent trials.

Source access and review scope

Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.

Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.

Source type: Patent publication

Open original source or index record ↗

Citation and original source

Original source: В.Х. Хавинсон, В.Г. Морозов, В.И. Семенова, О.В. Чайка, Г.А. Рыжак. Pineal extracts: manufacturing and composition patent — RU2163129C1 RU2163129C1 · patent family 20236906 2001.

Molekul research summary: https://molekul.io/research/patent-ru2163129c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards